ELI LILLY & Co - 12 Jan 2026 SCHEDULE 13D Report for Aktis Oncology, Inc. Common Stock, $0.0001 par value per share (AKTSQ)

Filing Manager
ELI LILLY & Co
Reporting Manager
Eli Lilly and Company
Security
Aktis Oncology, Inc. Common Stock, $0.0001 par value per share
Symbol
AKTSQ
Shares outstanding
53,311,882 shares
Disclosed Ownership
6,344,114 shares
Ownership
12%
Form type
SCHEDULE 13D
Filing time
15 Jan 2026, 06:02:12 UTC
Date of event
12 Jan 2026
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Eli Lilly and Company 12% 6,344,114 6,344,114 0 /s/ Christopher Anderson Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary 0000059478